Description

PRAZIOL 10 – Prasugrel Tablets IP 10 Mg 

Composition –  Prasugrel 10mg

Description:
PRAZIOL 10 contains Prasugrel Tablets IP 10 mg, a potent antiplatelet agent indicated for the prevention of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). It works by irreversibly inhibiting platelet aggregation, thereby reducing the risk of clot formation that can lead to heart attacks and other serious cardiovascular complications.

Key Points:

Potent Antiplatelet Action
• Effectively inhibits platelet aggregation to reduce thrombotic risk.

Cardiovascular Protection
• Helps lower the risk of recurrent heart attack and other ischemic events.

Post-PCI Management
• Commonly prescribed in patients undergoing angioplasty and stent placement.

Sustained Platelet Inhibition
• Provides consistent antiplatelet activity for long-term cardiovascular care.

Evidence-Based Therapy
• Widely used in the management of acute coronary syndrome as part of dual antiplatelet therapy.

Targeted Specialities:
• Cardiology
• Cardiology
• Internal Medicine
• Critical Care Medicine

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.